Coronary stenting with MGuard: First-in-man trial

Journal of Invasive Cardiology

Volumn 20, Issue 10, 2008, Pages 511-515

  Kaluski, Edo ^b,d   Hauptmann, Karl Eugen ^c   Müuller, Ralf ^a   Tsai, Steve ^b   Klapholz, Marc ^b   Grube, Eberhard ^a  

^a HELIOS Heart Center   (Germany)

^b Loyola University Medical Center   (United States)

^c KRANKENHAUS DER BARMHERZIGEN BRÜDER   (Germany)

^d University of Medicine and Dentistry of New Jersey   (United States)

Author keywords

Embolic protection device; Embolization; Restenosis; Stent thrombosis

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; CREATININE; FIBRINOGEN RECEPTOR ANTAGONIST; GLYCERYL TRINITRATE; HEPARIN; HIRULOG; METAL; PHOSPHOTRANSFERASE; TROPONIN;

ADULT; AGED; ANGIOGRAPHY; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY; CORONARY STENT; DEVICE; ELECTROCARDIOGRAPHY; EMBOLISM; FEASIBILITY STUDY; FEMALE; FOLLOW UP; HEART DEATH; HEART INFARCTION; HUMAN; LABORATORY TEST; MALE; PERCUTANEOUS CORONARY INTERVENTION; REVASCULARIZATION; RISK ASSESSMENT; THROMBOSIS; VEIN GRAFT;

AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CORONARY ARTERY DISEASE; CORONARY THROMBOSIS; CORONARY VESSELS; FEASIBILITY STUDIES; FEMALE; HUMANS; MALE; PLATELET AGGREGATION INHIBITORS; PROSPECTIVE STUDIES; STENTS; TRANSPLANTS;

EID: 57149087335     PISSN: 10423931     EISSN: 15572501     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Kaluski E, Groothuis A, Klapholz M, et al. Coronary stenting with M-Guard: Feasibility and safety porcine trial. J Invasive Cardiol 2007;19:326-330.
2. Popma JJ, Cox N, Hauptmann KE, et al. Initial clinical experience with distal protection using the FilterWire in patients undergoing coronary artery and saphenous vein graft percutaneous intervention. Catheter Cardiovasc Interv 2002;57:125-134.
3. Webb JG, Carere RG, Virmani R, et al. Retrieval and analysis of particulate debris after saphenous vein graft intervention. J Am Coll Cardiol 1999;34:468-475.
4. van Gaal WJ, Choudhury RP, Porto I, et al. Prediction of distal embolization during percutaneous coronary intervention in saphenous vein grafts. Am J Cardiol 2007;99:603-606.
5. Hofmann M, Störger H, Schwarz F, et al. Percutaneous saphenous vein graft interventions with and without distal filterwire protection. J Interv Cardiol 2005;18:475-479.
6. Baim DS, Wahr D, George B, et al; Saphenous vein graft Angioplasty Free of Emboli Randomized (SAFER) trial investigators. Randomized trial of a distal embolic protection device during percutaneous intervention of saphenous vein aorto-coronary bypass grafts. Circulation 2002;105:1285-1290.
7. Halkin A, Masud AZ, Rogers C, et al. Six-month outcomes after percutaneous intervention for lesions in aortocoronary saphenous vein grafts using distal protection devices: Results from the FIRE trial. Am Heart J 2006;151:915.
8. Stone GW, Rogers C, Hermiller J, et al; FilterWire EX Randomized Evaluation Investigators. Randomized comparison of distal protection with a filter-based catheter and a balloon occlusion and aspiration system during percutaneous intervention of diseased saphenous vein aorto-coronary bypass grafts. Circulation 2003;108:548-553.
9. Carrozza JP Jr, Mumma M, Breall JA, et al; PRIDE Study Investigators. Randomized evaluation of the TriActiv balloon-protection flush and extraction system for the treatment of saphenous vein graft disease. J Am Coll Cardiol 2005;46:1677-1683.
10. Mauri L, Cox D, Hermiller J, et al.The PROXIMAL trial: Proximal protection during saphenous vein graft intervention using the Proxis Embolic Protection System: A randomized, prospective, multicenter clinical trial. J Am Coll Cardiol 2007;50:1442-1449.
11. Cohen DJ, Murphy SA, Baim DS, et al; SAFER Trial Investigators. Cost-effectiveness of distal embolic protection for patients undergoing percutaneous intervention of saphenous vein bypass grafts: Results from the SAFER trial. J Am Coll Cardiol 2004;44:1801-1808.
12. Mehta SK, Frutkin AD, Milford-Beland S, et al; American College of Cardiology-National Cardiovascular Data Registry. Utilization of distal embolic protection in saphenous vein graft interventions (an analysis of 19,546 patients in the American College of Cardiology-National Cardiovascular Data Registry). Am J Cardiol 2007;100:1114-1118.
13. Giugliano GR, Kuntz RE, Popma JJ, et al; Saphenous Vein Graft Angioplasty Free of Emboli Randomized (SAFER) Trial Investigators. Determinants of 30-day adverse events following saphenous vein graft intervention with and without a distal occlusion embolic protection device. Am J Cardiol 2005;95:173-177.
14. Costantini CO, Stone GW, Mehran R, et al. Frequency, correlates, and clinical implications of myocardial perfusion after primary angioplasty and stenting, with and without glycoprotein IIb/IIIa inhibition, in acute myocardial infarction. J Am Coll Cardiol 2004;44:305-312.
15. Fukuda D, Tanaka A, Shimada K, et al. Predicting angiographic distal embolization following percutaneous coronary intervention in patients with acute myocardial infarction. Am J Cardiol 2003;91:403-407.
16. Bartorelli AL, Koh TH, Di Pede F, et al. Distal embolic protection during percutaneous coronary intervention in patients with acute coronary syndromes: The RUBY study. Acute Card Care 2006;8:148-154.
17. Maekawa Y, Asakura Y, Anzai T, et al. Relation of stent overexpansion to the angiographic no-reflow phenomenon in intravascular ultrasound-guided stent implantation for acute myocardial infarction. Heart Vessels 2005;20:13-18.
18. Kawaguchi R, Hoshizaki H, Hiratsuji T, et al. Effectiveness of distal protection with the GuardWire Plus during primary angioplasty for acute myocardial infarction. J Cardiol 2005;45:99-106.
19. Stone GW, Webb J, Cox DA, et al; Enhanced Myocardial Efficacy and Recovery by Aspiration of Liberated Debris (EMERALD) Investigators. Distal microcirculatory protection during percutaneous coronary intervention in acute ST-segment elevation myocardial infarction: A randomized controlled trial. JAMA 2005;293:1063-1072.
20. Gick M, Jander N, Bestehorn HP, et al. Randomized evaluation of the effects of filter-based distal protection on myocardial perfusion and infarct size after primary percutaneous catheter intervention in myocardial infarction with and without ST-segment elevation. Circulation 2005;112:1462-1469.
21. Porto I, Selvanayagam JB, Van Gaal WJ, et al. Plaque volume and occurrence and location of periprocedural myocardial necrosis after percutaneous coronary intervention: Insights from delayed-enhancement magnetic resonance imaging, thrombolysis in myocardial infarction myocardial perfusion grade analysis, and intravascular ultrasound. Circulation 2006;114:662-669.
22. Selvanayagam JB, Cheng AS, Jerosch-Herold M, et al. Effect of distal embolization on myocardial perfusion reserve after percutaneous coronary intervention: A quantitative magnetic resonance perfusion study. Circulation 2007;116:1458-1464.
23. Taylor AJ, Al-Saadi N, Abdel-Aty H, et al. Elective percutaneous coronary intervention immediately impairs resting microvascular perfusion assessed by cardiac magnetic resonance imaging. Am Heart J 2006;151:891.
24. Balian V, Galli M, Marcassa C, et al. Intracoronary ST-segment shift soon after elective percutaneous coronary intervention accurately predicts periprocedural myocardial injury. Circulation 2006;114:1948-1954.
25. Selvanayagam JB, Porto I, Channon K, et al. Troponin elevation after percutaneous coronary intervention directly represents the extent of irreversible myocardial injury: Insights from cardiovascular magnetic resonance imaging. Circulation 2005;111:1027-1032.